Nickenig G, Strehlow K, Bäumer A T, Baudler S, Wassmann S, Sauer H, Böhm M
Klinik III für Innere Medizin, Universität Köln, Joseph-Stelzmann Strasse 9, 50925 Köln, Germany.
Br J Pharmacol. 2000 Oct;131(4):795-803. doi: 10.1038/sj.bjp.0703623.
Free radicals as well as the AT1 receptor are involved in the pathogenesis of cardiovascular disease. Both the intracellular mechanisms of AT1 receptor regulation and the effect of free radicals on AT1 receptor expression are currently unknown. This study investigates the role of free radicals in the modulation of AT1 receptor expression and in the angiotensin II-induced AT1 receptor regulation. AT1 receptor mRNA was assessed by Northern blotting and AT1 receptor density by radioligand binding assays, respectively, in vascular smooth muscle cells (VSMC). Free radical release was measured by confocal laser scanning microscopy. AT1 receptor mRNA transcription rate was determined by nuclear run-on assays and AT1 receptor mRNA half-life was measured under transcriptional blockade. Angiotensin II caused a time-dependent decrease of AT1 receptor mRNA expression in rat VSMC in culture (30+/-6% at 4 h with 100 nM angiotensin II). This was followed by a consistent decrease in AT1 receptor density. Angiotensin II caused release of reactive oxygen species in VSMC which was abolished by preincubation with 100 microM diphenylene iodonium (DPI). DPI inhibited partially the down-regulating effect of angiotensin II on the AT1 receptor. Incubation of VSMC with either hydrogen peroxide or xanthine/xanthine oxidase caused a dose-dependent decrease in AT1 receptor mRNA expression which was not mediated by a decreased rate of transcription but rather through destabilization of AT1 receptor mRNA. Experiments which included preincubation of VSMC with various intracellular inhibitors suggested that free radicals caused AT1 receptor downregulation through activation of p38-MAP kinase and intracellular release of calcium. However, angiotensin II-induced AT1 receptor expression was not inhibited by blockade of p38-MAP kinase activation or intracellular calcium release. Free radicals may at least in part mediate angiotensin II-induced AT1 receptor regulation through direct post-transcriptional effects on AT1 receptor mRNA expression which involves intracellular release of calcium and activation of p38-MAP kinase. These findings may help to clarify the intracellular mechanisms involved in AT1 receptor regulation and reveal a novel biological feature for reactive oxygen species.
自由基以及血管紧张素Ⅱ 1型受体(AT1受体)均参与心血管疾病的发病机制。目前,AT1受体调节的细胞内机制以及自由基对AT1受体表达的影响尚不清楚。本研究旨在探讨自由基在调节AT1受体表达以及在血管紧张素Ⅱ诱导的AT1受体调节中的作用。分别通过Northern印迹法评估血管平滑肌细胞(VSMC)中的AT1受体mRNA,通过放射性配体结合试验评估AT1受体密度。通过共聚焦激光扫描显微镜测量自由基释放。通过细胞核转录分析确定AT1受体mRNA转录率,并在转录阻断条件下测量AT1受体mRNA半衰期。血管紧张素Ⅱ导致培养的大鼠VSMC中AT1受体mRNA表达呈时间依赖性下降(100 nM血管紧张素Ⅱ作用4小时时下降30±6%)。随后AT1受体密度持续下降。血管紧张素Ⅱ导致VSMC中活性氧释放,预先用100 μM二苯碘鎓(DPI)孵育可消除这种释放。DPI部分抑制血管紧张素Ⅱ对AT1受体的下调作用。用过氧化氢或黄嘌呤/黄嘌呤氧化酶孵育VSMC导致AT1受体mRNA表达呈剂量依赖性下降,这不是由转录速率降低介导的,而是通过AT1受体mRNA的不稳定介导的。包括用各种细胞内抑制剂预先孵育VSMC的实验表明,自由基通过激活p38丝裂原活化蛋白激酶(p38-MAP激酶)和细胞内钙释放导致AT1受体下调。然而,p38-MAP激酶激活或细胞内钙释放的阻断并未抑制血管紧张素Ⅱ诱导的AT1受体表达。自由基可能至少部分通过对AT1受体mRNA表达的直接转录后效应介导血管紧张素Ⅱ诱导的AT1受体调节,这涉及细胞内钙释放和p38-MAP激酶激活。这些发现可能有助于阐明AT1受体调节所涉及的细胞内机制,并揭示活性氧的一种新的生物学特性。